
Mecorise-PR Tablet SR
Marketer
Altavista Life Sciences Pvt Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Mecorise-PR Tablet SR
Gabapentinoid extended-release tablets are prescribed for neuropathic pain management. They alleviate pain by regulating nerve cell calcium channels, promoting nerve fiber protection and repair of damaged nerve cells. Administered orally, with or without food, ideally before sleep, consistent daily timing ensures stable drug levels. Adhere strictly to the prescribed dosage and duration, as this medication can be habit-forming. Missed doses should be taken immediately upon recall. Complete the entire course, even with symptom improvement. Abrupt cessation is strongly discouraged without physician consultation. Common side effects, such as upper respiratory symptoms, increased hunger, elevated mood, shaking, vision blurring, dry mouth, lightheadedness, and drowsiness, are generally mild and improve over time. Avoid activities requiring concentration until the drug's effects are known. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor. Disclose all other medications you are taking, as interactions may reduce efficacy or alter the drug's action. Notify your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Mecorise-PR Tablet SR
Managing Neuropathic Pain
Major Benefits of Mecorise-PR Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mecorise-PR Tablet SR can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Mecorise-PR Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Mecorise-PR Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecorise-PR Tablet SR can be consumed with or without food, although consistent daily timing is recommended.
How Mecorise-PR Tablet SR works:
Mecorise-PR SR tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin production, shielding nerve fibers and aiding in the repair of damaged nerve cells. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modifying calcium channel function within nerve cells. This combined action provides effective relief from the discomfort of nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecorise-PR Tablet SR and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Mecorise-PR Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Mecorise-PR tablets likely pose a breastfeeding safety risk. Available human data indicate potential drug transfer to breast milk, possibly endangering the infant.
DrivingUNSAFE
Driving should be avoided if using Mecorise-PR Tablet SR, as it can cause drowsiness, blurred vision, and dizziness, thereby reducing alertness.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Mecorise-PR Tablet SR. Dosage modifications for Mecorise-PR Tablet SR may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Mecorise-PR Tablet SR in individuals with hepatic impairment appears to present a low risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mecorise-PR Tablet SR :
Should you forget a dose of Mecorise-PR Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecorise-PR Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
